CORZ Institutional Investors Pile In as Core Scientific Shifts to AI/HPC and Colocation

• Oaktree Capital Management LP added 1,950,000 shares of Core Scientific (CORZ) to its portfolio, reflecting growing institutional interest in the stock.
• Oasis Management disclosed a new position in Core Scientific, acquiring 2,643,729 shares worth $38.49 million, representing 2.5% of its reportable U.S. equity assets as of December 31, 2025.
• Helix Partners Management increased its stake in Core Scientific by 350,000 shares in Q4 2026, with a transaction value of $6.10 million, despite a $12.65 million decline in position value due to stock price volatility.

Core Scientific is undergoing a strategic shift from traditional Bitcoin mining to high-density colocation and AI/HPC computing services. This transition aims to diversify revenue streams and mitigate risks associated with the volatile cryptocurrency market. The company's high-density colocation revenue increased from $10.3 million to $15.0 million in the latest quarter, indicating progress in its strategic pivot.

The move to focus on AI and HPC workloads aligns with broader industry trends and is seen as a way to stabilize revenue and capture opportunities in high-performance computing. However, analysts remain divided, with some expressing optimism over infrastructure advantages and long-term growth potential while others caution about uncertain revenue visibility and unproven profitability.

Why Are Institutional Investors Increasing Their Holdings in Core Scientific?

Institutional investors such as Oaktree, Oasis Management, and Helix Partners are adding to their stakes in Core Scientific amid its strategic transformation. Oaktree's addition of 1.95 million shares and Oasis Management's $38.49 million investment suggest a belief in the company's pivot to colocation and AI/HPC. Helix Partners also increased its holdings, even as stock price volatility affected the position value.

These investments may reflect confidence in Core Scientific's potential to capitalize on the growing demand for computing resources in AI and scientific applications. With its colocation revenue on the rise and a pivot away from Bitcoin mining, the company is positioning itself for a more diversified and stable income stream.

What Are the Risks and Limitations of Core Scientific's Strategic Shift?

Despite the strategic pivot, Core Scientific's transition is not without risks. Analysts highlight concerns around revenue visibility and unproven profitability as key challenges. The company reported a net loss of $146.7 million in Q3 2023, raising questions about its financial sustainability. While the company maintains a liquidity buffer of $694.8 million, the long-term success of its new business model will depend on execution and market demand.

Additionally, Core Scientific's stock price remains volatile, with a 44.6% rise over the past year but mixed momentum indicators signaling caution. The company must demonstrate consistent revenue growth and profitability to sustain investor confidence.

How Does Core Scientific's Strategic Shift Align With Industry Trends?

The shift toward colocation and AI/HPC aligns with broader industry movements toward high-performance computing and data center infrastructure. With companies like MicroStrategy also adopting alternative capital structures to support Bitcoin holdings, the demand for alternative infrastructure and computing resources is rising. Core Scientific's pivot positions it to compete in this evolving landscape.

However, the company's performance will need to show tangible improvements in revenue and profitability to justify the strategic shift. As the market continues to evolve, Core Scientific's ability to adapt and innovate will be key to its long-term success.